Advances in cell and gene-based therapies for cystic fibrosis lung disease
- PMID: 22371844
- PMCID: PMC3369283
- DOI: 10.1038/mt.2012.32
Advances in cell and gene-based therapies for cystic fibrosis lung disease
Abstract
Cystic fibrosis (CF) is a disease characterized by airway infection, inflammation, remodeling, and obstruction that gradually destroy the lungs. Direct delivery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene to airway epithelia may offer advantages, as the tissue is accessible for topical delivery of vectors. Yet, physical and host immune barriers in the lung present challenges for successful gene transfer to the respiratory tract. Advances in gene transfer approaches, tissue engineering, and novel animal models are generating excitement within the CF research field. This review discusses current challenges and advancements in viral and nonviral vectors, cell-based therapies, and CF animal models.
Figures


Comment in
-
The challenge of using gene- or cell-based therapies to treat lung disease.Mol Ther. 2012 Jun;20(6):1077-8. doi: 10.1038/mt.2012.91. Mol Ther. 2012. PMID: 22652992 Free PMC article. No abstract available.
Similar articles
-
Genetic therapies for cystic fibrosis lung disease.Hum Mol Genet. 2011 Apr 15;20(R1):R79-86. doi: 10.1093/hmg/ddr104. Epub 2011 Mar 21. Hum Mol Genet. 2011. PMID: 21422098 Free PMC article. Review.
-
Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights.Curr Med Sci. 2024 Dec;44(6):1155-1174. doi: 10.1007/s11596-024-2936-5. Epub 2024 Dec 16. Curr Med Sci. 2024. PMID: 39676146 Review.
-
Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.Hum Gene Ther. 2020 May;31(9-10):524-537. doi: 10.1089/hum.2020.013. Epub 2020 Apr 15. Hum Gene Ther. 2020. PMID: 32138545 Free PMC article. Review.
-
Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.Hum Gene Ther. 1998 Mar 20;9(5):635-48. doi: 10.1089/hum.1998.9.5-635. Hum Gene Ther. 1998. PMID: 9551612
-
Cell-Based Therapeutic Approaches for Cystic Fibrosis.Int J Mol Sci. 2020 Jul 23;21(15):5219. doi: 10.3390/ijms21155219. Int J Mol Sci. 2020. PMID: 32718005 Free PMC article. Review.
Cited by
-
Role of extracellular vesicles in chronic lung disease.Thorax. 2021 Oct;76(10):1047-1056. doi: 10.1136/thoraxjnl-2020-216370. Epub 2021 Mar 12. Thorax. 2021. PMID: 33712504 Free PMC article. Review.
-
Transduction of Pig Small Airway Epithelial Cells and Distal Lung Progenitor Cells by AAV4.Cells. 2021 Apr 25;10(5):1014. doi: 10.3390/cells10051014. Cells. 2021. PMID: 33923029 Free PMC article.
-
Efficient intratracheal delivery of airway epithelial cells in mice and pigs.Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L221-8. doi: 10.1152/ajplung.00147.2014. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 25416381 Free PMC article.
-
Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium.Nat Commun. 2015 Apr 27;6:6952. doi: 10.1038/ncomms7952. Nat Commun. 2015. PMID: 25914116 Free PMC article.
-
Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors.Mol Ther Nucleic Acids. 2013 Jan 29;2(1):e69. doi: 10.1038/mtna.2012.60. Mol Ther Nucleic Acids. 2013. PMID: 23360952 Free PMC article.
References
-
- Welsh MJ, Tsui LC, Boat TF., and, Beaudet AL.1995Cystic fibrosis Scriver CR, Beaudet AL, Sly WS., and, Valle D.eds). The Metabolic and Molecular Basis of Inherited Disease7th edn., vol. 3. McGraw-Hill: New York; pp. 3799–3876.
-
- Davis PB, Drumm M., and, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154:1229–1256. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical